Department of Radiation Oncology
Lung Cancer
-
Technical Advantages
-
Equipment Advantages
-
Leading Experts
Technical Advantages
Technical Advantages
The Department of Radiation Oncology specializes in the precise diagnosis and treatment of lung cancer. The technical advantages are as follows
-
Each patient undergoes a multidisciplinary team (MDT) approach to develop standardized and professional treatment plans based on evidence-based medicine; -
Precise radiotherapy techniques, including IMRT, IGRT, VMAT, and respiratory gating technology, and based on specific molecular targeted probe examinations (e.g., PSMA PET-CT), enable more precise irradiation, which can both improve tumor treatment outcomes and effectively reduce side effects; -
Provides access to the most advanced proton and heavy ion therapy resources and international consultation services, enabling patients in need to receive the most advanced and authoritative treatment recommendations and related medical pathways currently available worldwide.
Equipment Advantages
Equipment Advantages
-
1
The latest generation GE Discovery MI PET/CT and NM/CT 870 SPECT/CT system: Achieves comprehensive coverage from molecular imaging diagnosis of genitourinary tumors to routine split renal function (GFR) evaluation. In particular, the application of the novel molecular probe 18F-PSMA (prostate-specific membrane antigen ligand) provides new means for early diagnosis, initial staging, biochemical recurrence and efficacy evaluation of prostate cancer, as well as assessment of tumor heterogeneity and biological behavior.
-
2
The world's most advanced Hitachi integrated proton and heavy ion radiotherapy system: Utilizes internationally leading proton and heavy ion technology. Proton and heavy ion therapy features a unique "Bragg Peak" effect, which precisely concentrates radiation energy on the tumor tissue, greatly minimizing damage to normal tissues. It is particularly suitable for pediatric tumors, head and neck tumors, brain tumors, hepatobiliary and pancreatic tumors, and patients with poor radiotherapy tolerance.
-
3
Varian TrueBEAM with HyperArc: The Varian TrueBEAM linear accelerator is equipped with HyperArc technology, enabling ultra-high precision stereotactic body radiotherapy (SBRT/SRS). HyperArc technology can precisely treat multiple tumor lesions simultaneously in a very short time, especially suitable for patients with brain metastases, significantly improving tumor control rates, reducing the number of treatment sessions, and enhancing the patient treatment experience.
-
4
Adaptive Radiotherapy (Adaptive RT): Utilizes cutting-edge adaptive radiotherapy technology to adjust the treatment plan in real-time based on changes in tumor morphology and position throughout the radiotherapy course. Through real-time image monitoring and precise dynamic adjustments, it effectively enhances treatment outcomes, maximizes the protection of normal tissues, and ensures each patient receives the most precise and safest treatment experience."
Leading Experts
Lu Jiade
Doctor of Medicine, Master of Management, Professor
Professional Resume
National High-Level Talent, National Distinguished Expert, Chief Scientist of the National Key R&D Program; Professor at Soochow University, Clinical Oncology Professor at Fudan University; Former Executive Vice President of Shanghai Proton and Heavy Ion Hospital, Former Vice President of Singapore General Hospital; Member of the Steering Committee of Heyou International Hospital Group, Vice President of Heyou Hospital; Director of the Oncology Medical Center and Proton and Heavy Ion Center, Heyou Hospital.
Areas of Expertise
Scan WeChat Code to Book
